Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 19/20 | 0.79 |
| ▸ | MAP2K2 | P36507 | 3/20 | 0.79 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 0.79 |
| ▸ | EIF2AK1 | Q9BQI3 | 1/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18576802 | 0.90 | MAP2K1 (0.82) | MAP2K1MAP2K2MAP2K5EIF2AK1CYP2C9 | |
| SCHEMBL393158 | 0.89 | MAP2K1 (0.79) | MAP2K1MAP2K2MAP2K5EIF2AK1 | |
| Azd-8330 SCHEMBL29360392 | 0.89 | MAP2K1 (1.00) | MAP2K1MAP2K2MAP2K5EIF2AK1CYP2C9 | |
| SCHEMBL12295137 | 0.89 | MAP2K1 (0.79) | MAP2K1MAP2K2MAP2K5EIF2AK1CYP2C9 | |
| Azd-8330 SCHEMBL388533 | 0.89 | MAP2K1 (1.00) | MAP2K1MAP2K2MAP2K5EIF2AK1CYP2C9 | |
| SCHEMBL392617 | 0.87 | MAP2K1 (0.77) | MAP2K1MAP2K2MAP2K5EIF2AK1CYP2C9 | |
| SCHEMBL392221 | 0.83 | MAP2K1 (0.79) | MAP2K1MAP2K2MAP2K5EIF2AK1CYP2C9 | |
| SCHEMBL393671 | 0.83 | MAP2K1 (0.65) | MAP2K1MAP2K2MAP2K5EIF2AK1 | |
| SCHEMBL387711 | 0.82 | MAP2K1 (0.81) | MAP2K1MAP2K2MAP2K5EIF2AK1CYP2C9 | |
| SCHEMBL388763 | 0.82 | MAP2K1 (0.67) | MAP2K1MAP2K2MAP2K5EIF2AK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2600862-B1 | INHIBITORS OF ERK FOR DEVELOPMENTAL DISORDERS OF NEURONAL CONNECTIVITY | UNIV CASE WESTERN RESERVE (US) | 2016-04-20 | — | — | EP | claimed |
| US-20150141380-A1 | INHIBITORS OF ERK FOR DEVELOPMENTAL DISORDERS OF NEURONAL CONNECTIVITY | CASE WESTERN RESERVE UNIVERSITY (US) | 2015-05-21 | — | — | US | claimed |
| EP-2600862-A2 | INHIBITORS OF ERK FOR DEVELOPMENTAL DISORDERS OF NEURONAL CONNECTIVITY | Case Western Reserve University (US) | 2013-06-12 | — | — | EP | claimed |
| WO-2012019113-A2 | INHIBITORS OF ERK FOR DEVELOPMENTAL DISORDERS OF NEURONAL CONNECTIVITY | CASE WESTERN RESERVE UNIVERSITY (US) | 2012-02-09 | — | — | WO | claimed |
| US-10941194-B2 | Methods of diagnosing and treating autism spectrum disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-03-09 | — | — | US | disclosed |
| US-20180002410-A1 | METHODS OF DIAGNOSING AND TREATING AUTISM SPECTRUM DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-01-04 | — | — | US | disclosed |
| EP-2600862-B1 | INHIBITORS OF ERK FOR DEVELOPMENTAL DISORDERS OF NEURONAL CONNECTIVITY | UNIV CASE WESTERN RESERVE (US) | 2016-04-20 | — | — | EP | disclosed |
| US-20150141380-A1 | INHIBITORS OF ERK FOR DEVELOPMENTAL DISORDERS OF NEURONAL CONNECTIVITY | CASE WESTERN RESERVE UNIVERSITY (US) | 2015-05-21 | — | — | US | disclosed |
| EP-2600862-A2 | INHIBITORS OF ERK FOR DEVELOPMENTAL DISORDERS OF NEURONAL CONNECTIVITY | Case Western Reserve University (US) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012019113-A2 | INHIBITORS OF ERK FOR DEVELOPMENTAL DISORDERS OF NEURONAL CONNECTIVITY | CASE WESTERN RESERVE UNIVERSITY (US) | 2012-02-09 | — | — | WO | disclosed |